$35MSeries D, 14 October 2025
Funds clinical operations, development and commercialization preparation.
- Amount
- $35M
- Stage
- Series D
- Announced
- 14 October 2025
- Lead
- J.P. Morgan Life Sciences Private Capital
- Other investors
- F-Prime, Santé Ventures, Eight Roads Ventures
- Use of funds
- Funds clinical operations, development and commercialization preparation.
- Checked
- Announced by the company
- Sources
- ABK Biomedical Raises US$35M in Series D Financing - PR Newswire biospace.com
ABK Biomedical Raises US$35M in Series D Financing - PR Newswire PR Newswire